Citigroup Cuts Penumbra (NYSE:PEN) Price Target to $320.00

Penumbra (NYSE:PEN – Get Free Report) had its price objective dropped by investment analysts at Citigroup from $390.00 to $320.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price objective indicates a potential upside of 35.08% from the company’s […]

Related Keywords

New Mexico ,United States ,Canada ,Robertw Baird ,Zurcher Kantonalbank Zurich Cantonalbank ,Adam Elsesser ,Thomas Wilder ,Canaccord Genuity Group ,Citigroup ,Penumbra Inc ,Royal Bank ,Securities Exchange Commission ,Deutsche Bank Aktiengesellschaft ,Get Free Report ,Bank Aktiengesellschaft ,Genuity Group ,Director Thomas Wilder ,Exchange Commission ,Kantonalbank Zurich Cantonalbank ,Mexico Educational Retirement Board ,Capital Management ,Asset Management ,Rhumbline Advisers ,Penumbra System ,Revascularization Device ,Penumbra Coil ,Penumbra Daily ,Penumbra ,Nyse Pen ,Pen ,Medical ,Lower Price Target ,Citigroup Inc ,